Navin Saxena Research and Technology Centre
NSRT is a research-driven enterprise focused on developing innovative pharmaceutical technologies to improve healthcare. With over 25 years of experience, NSRT specializes in computer-aided drug design, synthesis of active pharmaceutical ingredients, development of new drug delivery systems, and contract manufacturing. Certified ISO 9001:2015, NSRT aims to be a global leader in scientific drug delivery technologies.
Industries
Nr. of Employees
medium (51-250)
Navin Saxena Research and Technology Centre
Products
Transdermal patches (matrix and hydrogel)
Development and manufacture of hydrophobic matrix patches for controlled systemic delivery and hydrophilic hydrogel patches for topical application.
Implantable sustained-release devices
Polymer-based subcutaneous/intramuscular implants engineered for linear drug release over weeks to months.
Oral solid dosage forms (tablets, capsules, pellets)
Development and manufacture of generic and layered tablets, sustained-release and abuse-deterrent oral solids.
Semi-solid and liquid formulations
Formulation and production of creams, ointments and non-sterile liquid dosage forms.
Injectable formulations (immediate, lyophilized, depot)
Immediate-release solutions, lyophilized injections for solubility/stability, and depot injections for long-acting delivery.
Nanoformulations and vesicular systems
Vesicular formulations (liposomes, niosomes, transfersomes, ethosomes), particulate systems (nanoparticles, microspheres), micelles, emulsions and SEDDS for improved bioavailability and targeted delivery.
Transdermal patches (matrix and hydrogel)
Development and manufacture of hydrophobic matrix patches for controlled systemic delivery and hydrophilic hydrogel patches for topical application.
Implantable sustained-release devices
Polymer-based subcutaneous/intramuscular implants engineered for linear drug release over weeks to months.
Oral solid dosage forms (tablets, capsules, pellets)
Development and manufacture of generic and layered tablets, sustained-release and abuse-deterrent oral solids.
Semi-solid and liquid formulations
Formulation and production of creams, ointments and non-sterile liquid dosage forms.
Injectable formulations (immediate, lyophilized, depot)
Immediate-release solutions, lyophilized injections for solubility/stability, and depot injections for long-acting delivery.
Nanoformulations and vesicular systems
Vesicular formulations (liposomes, niosomes, transfersomes, ethosomes), particulate systems (nanoparticles, microspheres), micelles, emulsions and SEDDS for improved bioavailability and targeted delivery.
Services
Contract Research & Development
Outsourced research services including CADD, new-molecule API development, synthetic route optimization, impurity synthesis, formulation development across transdermal, implantable, oral, semi-solid, injectable and nanoformulations, and analytical method development/validation.
Contract Manufacturing & Analytical Services
Commercial manufacturing of APIs and finished dosage forms (tablets, capsules, granules, patches, non-sterile liquids, semi-solids) and routine/advanced analytical testing.
Contract Research & Development
Outsourced research services including CADD, new-molecule API development, synthetic route optimization, impurity synthesis, formulation development across transdermal, implantable, oral, semi-solid, injectable and nanoformulations, and analytical method development/validation.
Contract Manufacturing & Analytical Services
Commercial manufacturing of APIs and finished dosage forms (tablets, capsules, granules, patches, non-sterile liquids, semi-solids) and routine/advanced analytical testing.
Expertise Areas
- Drug substance synthesis and scale-up
- Novel drug delivery systems (NDDS)
- Transdermal delivery systems
- Implantable and depot delivery platforms
Key Technologies
- Computer-aided drug design (CADD)
- In-silico toxicity prediction
- Continuous flow chemistry
- Multifunctional jacketed reactors and SCADA control